ArticlePharmacoEconomics - open2024

Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina.

Natalia Espinola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.